These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3074243)

  • 21. [Shigella surface K-angigens and their role in virulence].
    Belaia IuA; Kostenko LS; Ivanov KK; Petrukhin VG
    Vestn Akad Med Nauk SSSR; 1973; 28(11):35-44. PubMed ID: 4594835
    [No Abstract]   [Full Text] [Related]  

  • 22. [Etiological factors in bacillary dysentery in Poland 1965-1979].
    Stypułkowska-Misiurewicz H; Adonajło A
    Przegl Epidemiol; 1981; 35(4):443-53. PubMed ID: 7041196
    [No Abstract]   [Full Text] [Related]  

  • 23. [The antigenic structure of shigellae. 4. Isolation and purification of a thermolabile antigen of SH. sonnei].
    Seltmann G
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):324-35. PubMed ID: 4122375
    [No Abstract]   [Full Text] [Related]  

  • 24. [The immunobiological properties of the lipopolysaccharides of bacteria in the genus Shigella with contrasting virulence and their chemically modified analogs].
    Borisova EV
    Mikrobiol Z; 1999; 61(4):64-71. PubMed ID: 10565153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of the synergistic action of enterotoxin on the specific protective complex of Shigella sonnei].
    Korneeva SA; Kovalevskaia IL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Dec; (12):38-41. PubMed ID: 1789032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radioprotective properties of Shigella antigens].
    Gorbunova ES; Mal'tsev VN; Tiurin EA
    Radiobiologiia; 1981; 21(4):591-4. PubMed ID: 7029609
    [No Abstract]   [Full Text] [Related]  

  • 27. [Separation of Shigella toxins into fractions differing in biological activity and characteristics of the fractions inducing penetration in avirulent strains].
    Miroliubova LV; Petrovskaia VG; Lycheva IA; Beliaev DL
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):21-8. PubMed ID: 7034411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enterotoxin production by Shigella flexneri type 2A, strain no. M42-43.
    Kétyi I; Vertényi A; Pácsa S; Kocsis B
    Acta Microbiol Acad Sci Hung; 1978; 25(4):319-25. PubMed ID: 382758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Suppression of the immune response by Shigella in experimental influenza infection in mice].
    Frolov AF; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):104-8. PubMed ID: 6760625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunosuppressive activity of Shigella sonnei differing by the presence of plasmid pSS120].
    Borisova EV; Bondarenko VM; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):65-8. PubMed ID: 9460870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunosuppressive activity of chemically modified lipopolysaccharide of Shigella sonnei.
    Vikström EV
    Immunol Lett; 2002 Jan; 80(1):15-9. PubMed ID: 11716960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
    Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
    [No Abstract]   [Full Text] [Related]  

  • 33. [Isolation of endotoxin-free Shigella sonnei enterotoxin from a neurotoxin preparation].
    Iarovaia LM; Kamzolkina NB; Kholchev NV; Kamenskaia IN; Margulis IL
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Apr; (4):84-7. PubMed ID: 6996396
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of pancrealysates of Sh. flexneri 2a and Sh. sonnei fractionated by filtration through Sephadex G-200 and ultracentrifugation].
    Kaverina KG; Shuvaeva LP; Zhvanetskaia MI; Rostovtseva NA; Kreinin LS
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jul; (7):51-6. PubMed ID: 795248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between Congo red binding and contact haemolysin production in Shigella species.
    Sharma K; Rishi P; Grewal JS; Ram S; Tiwari RP
    Microbios; 2001; 106(413):31-8. PubMed ID: 11491522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nonspecific Shigella suppression of delayed hypersensitivity].
    Borisov VA; Frolov AF
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Mar; (3):21-4. PubMed ID: 7043973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The immunosuppressive activity of filtrates of the culture broth from nonvirulent salmonellae].
    Molozhavaia OS; Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(2):73-8. PubMed ID: 9221061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental model of high-dosage immunological tolerance to Shigella sonnei lipopolysaccharide].
    Borisov VA; Gofman IL
    Mikrobiol Zh (1978); 1980; 42(6):723-6. PubMed ID: 7007829
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oral immunization of mice with Shigella sonnei antigens].
    Thilo W; Weister A
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):294-302. PubMed ID: 4921005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.